UBTECH's H1 Revenue Doubles as Humanoid Robot Sales Surge Nearly 20-Fold
nashnova research
UBTECH posted RMB 1.27 billion in H1 revenue — up 104% year-on-year — while humanoid robot shipments hit 921 units, a nearly 20× jump. Net losses narrowed 23%, signaling early scale effects, but per-unit profitability remains the next test.
What do the headline numbers actually say?
Revenue hit RMB 1.27 billion, up 104% YoY. Gross profit reached RMB 567 million, up 161%. Gross profit growing faster than revenue means each yuan of sales is yielding more margin.
Net loss stood at RMB 339 million, narrowing 23% YoY. This means → revenue doubled but losses shrank by less than a quarter — the break-even point is not here yet, but the direction is right.
In plain terms = the company is still burning cash, but burning it more efficiently — spending similar amounts while pulling in far more revenue.
921 humanoid robots shipped — what does that signal?
Humanoid robot revenue reached RMB 590 million, up 1,445% YoY. Unit sales hit 921, up 1,947%.
This means → humanoid robots have jumped from "a few dozen trial units" to "close to a thousand deliveries" — commercialization has entered a new order of magnitude.
RMB 590 million accounts for nearly half of total revenue. This reflects a structural shift: the growth engine is no longer education robots — it is humanoids.
What is UBTECH building on the tech and product side?
On the technology layer, four clusters are advancing: an embodied brain (the AI system for understanding and decision-making), a humanoid cerebellum (balance and motion control), a high-performance body (the physical hardware), and swarm intelligence (coordinating multiple robots together).
Three product lines run in parallel: the industrial Walker S series for factory floors, the commercial Walker C series for service settings, and the hyper-bionic U1 series for education and home use.
In plain terms = the company is turning "build one robot" into "build one platform" — shared tech underneath, swappable shells on top for each use case. That is the only way to spread cost at scale.
What is the market watching in H2?
One metric matters most: whether per-unit losses keep falling. In H1, sales volume grew far faster than losses shrank, which means each robot is still sold at a loss.
This means → if H2 volumes stay high but per-unit losses stop compressing, the market will question whether "more volume" truly leads to "more profit."
Scale effects have just started to show. More quarters of data are needed to confirm the path actually works.
市场有风险，内容仅供研究参考，不构成投资建议。